Long-term dietary antioxidant cocktail supplementation effectively reduces renal inflammation in diabetic mice

British Journal of Nutrition

Volumn 106, Issue 10, 2011, Pages 1514-1521

  Park, Na Young ^a   Park, Seul Ki ^a   Lim, Yunsook ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Antioxidants; Diabetes mellitus; Diabetic nephropathy; Inflammation; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID; C REACTIVE PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; CREATININE; CYCLOOXYGENASE 2; GLUCOSE; HEME OXYGENASE 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIET SUPPLEMENTATION; FEMALE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UREA NITROGEN BLOOD LEVEL;

ACETYLCYSTEINE; ALLOXAN; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BLOOD UREA NITROGEN; BODY WEIGHT; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; LIPID PEROXIDATION; MICE; NEPHRITIS; OXIDATIVE STRESS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; MUS;

EID: 80755169309     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511001929     Document Type: Article

References (44)

1. Soman SS & Soman AS (2009) Diabetic nephropathy. http://emedicine. medscape.com/article/238946over.
2. Schrijvers BF, De Vriese AS & Flyvbjerg A (2004) From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 25, 971-1010. (Pubitemid 39657775)
3. Chow F, Ozols E, Nikolic-Paterson DJ, et al. (2004) Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 65, 116-128. (Pubitemid 38037496)
4. Ha H, Yu MR, Choi YJ, et al. (2002) Role of high glucoseinduced nuclear factor-kappaB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 13, 894-902. (Pubitemid 34274085)
5. Horie K, Miyata T, Maeda K, et al. (1997) Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 100, 2995-3004. (Pubitemid 28022836)
6. Maxwell SR, Thomason H, Sandler D, et al. (1997) Poor glycaemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes mellitus. Ann Clin Biochem 34, 638-644. (Pubitemid 27480966)
7. Maxwell SR, Thomason H, Sandler D, et al. (1997) Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 27, 484-490. (Pubitemid 27288358)
8. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, et al. (1997) Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40, 647-653. (Pubitemid 27288109)
9. Santini SA, Marra G, Giardina B, et al. (1997) Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46, 1853-1858. (Pubitemid 27456421)
10. Studer RK, Craven PA & DeRubertis FR (1997) Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism 46, 918-925. (Pubitemid 27339917)
11. Tada H, Ishii H & Isogai S (1997) Protective effect of D-alphatocopherol on the function of human mesangial cells exposed to high glucose concentrations. Metabolism 46, 779-784. (Pubitemid 27300620)
12. Giardino I, Edelstein D & Brownlee M (1996) BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 97, 1422-1428. (Pubitemid 26097031)
13. Bierhaus A, Chevion S, Chevion M, et al. (1997) Advanced glycation end product-induced activation of NF-kappaB is suppressed by alpha-lipoic acid in cultured endothelial cells. Diabetes 46, 1481-1490. (Pubitemid 27369087)
14. Osawa T & Kato Y (2005) Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann N Y Acad Sci 1043, 440-451. (Pubitemid 41123932)
15. Ho E, Chen G & Bray TM (1999) Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice. Faseb J 13, 1845-1854. (Pubitemid 29473348)
16. Lee EY, Lee MY, Hong SW, et al. (2007) Blockade of oxidative stress by vitamin C ameliorates albuminuria and renal sclerosis in experimental diabetic rats. Yonsei Med J 48, 847-855. (Pubitemid 350130477)
17. Ueno Y, Kizaki M, Nakagiri R, et al. (2002) Dietary glutathione protects rats from diabetic nephropathy and neuropathy. J Nutr 132, 897-900. (Pubitemid 34493549)
18. Nakhoul FM, Miller-Lotan R, Awad H, et al. (2009) Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus. Am J Physiol Renal Physiol 296, F830-F838.
19. Craven PA, DeRubertis FR, Kagan VE, et al. (1997) Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. J Am Soc Nephrol 8, 1405-1414.
20. Koya D, Lee IK, Ishii H, et al. (1997) Prevention of glomerular dysfunction in diabetic rats by treatment with D-alphatocopherol. J Am Soc Nephrol 8, 426-435. (Pubitemid 127454178)
21. Trachtman H, Futterweit S, Maesaka J, et al. (1995) Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Am J Physiol 269, F429-F438.
22. Packer L, Witt EH & Tritschler HJ (1995) Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 19, 227-250.
23. Ramadan G, El-Beih NM & Abd El-Ghffar EA (2009) Modulatory effects of black v. green tea aqueous extract on hyperglycaemia, hyperlipidaemia and liver dysfunction in diabetic and obese rat models. Br J Nutr 102, 1611-1619.
24. Ohkawa H, Ohishi N & Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95, 351-358. (Pubitemid 9194347)
25. Kedziora-Kornatowska K, Szram S, Kornatowski T, et al. (2003) Effect of vitamin E and vitamin C supplementation on antioxidative state and renal glomerular basement membrane thickness in diabetic kidney. Nephron Exp Nephrol 95, e134-e143. (Pubitemid 41309739)
26. Park SK, Park NY & Lim Y (2009) Effects of short term antioxidant cocktail supplementation on the oxidative stress and inflammatory response of renal inflammation in diabetic mice. Korean J Nutr 42, 673-681.
27. Kuhad A & Chopra K (2009) Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway. Life Sci 84, 296-301.
28. Rhoden CR, Lawrence J, Godleski JJ, et al. (2004) N-acetylcysteine prevents lung inflammation after short-term inhalation exposure to concentrated ambient particles. Toxicol Sci 79, 296-303. (Pubitemid 38786887)
29. Cay M, Naziroglu M, Simsek H, et al. (2001) Effects of intraperitoneally administered vitamin C on antioxidative defense mechanism in rats with diabetes induced by streptozotocin. Res Exp Med (Berl) 200, 205-213. (Pubitemid 32247180)
30. Renno WM, Abdeen S, Alkhalaf M, et al. (2008) Effect of green tea on kidney tubules of diabetic rats. Br J Nutr 100, 652-659.
31. Murali B & Goyal RK (2001) Effect of chronic treatment with losartan on streptozotocin induced diabetic nephropathy. Clin Exp Hypertens 23, 513-520. (Pubitemid 33031251)
32. Signorello MG, Viviani GL, Armani U, et al. (2007) Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Thromb Res 120, 607-613. (Pubitemid 47094910)
33. Kim MJ, Cho SY, Lee MK, et al. (2004) Effects of Aralia elata water extracts on activities of hepatic oxygen free radical generating and scavenging enzymes in streptozotocin-induced diabetic rats. J Korean Soc Food Sci Nut 33, 653-658.
34. Kruger AL, Peterson SJ, Schwartzman ML, et al. (2006) Upregulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects. J Pharmacol Exp Ther 319, 1144-1152.
35. Nath KA (2006) Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int 70, 432-443. (Pubitemid 44141569)
36. Hayashi K, Haneda M, Koya D, et al. (2001) Enhancement of glomerular heme oxygenase-1 expression in diabetic rats. Diabetes Res Clin Pract 52, 85-96. (Pubitemid 32335601)
37. Yamamoto Y & Gaynor RB (2001) Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest 107, 135-142. (Pubitemid 32096826)
38. Iwamoto M, Mizuiri S & Tanimoto H (2001) Nuclear factorkappaB activation in streptozotocin induced diabetic rats kidneys. J Am Soc Nephrol 12, 838a.
39. Lal M, Brismar H, Eklof AC, et al. (2001) Advanced glycation endproducts induced oxidative stress and activate NF-kB, PKC in mesangial cells. J Am Soc Nephrol 12, 840a.
40. Hofmann MA, Schiekofer S, Kanitz M, et al. (1998) Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes Care 21, 1310-1316. (Pubitemid 28365689)
41. Mohamed AK, Bierhaus A, Schiekofer S, et al. (1999) The role of oxidative stress and NF-kappaB activation in late diabetic complications. Biofactors 10, 157-167. (Pubitemid 29533824)
42. Pahl HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853-6866.
43. Eklund CM (2009) Proinflammatory cytokines in CRP baseline regulation. Adv Clin Chem 48, 111-136.
44. Goldberg RB (2009) Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 94, 3171-3182.